StockSelector.com
  Research, Select, & Monitor Sunday, May 26, 2019 7:01:37 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Heron Therapeutics Inc.$18.18$.452.54%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Heron Therapeutics Inc. has an overall rank of 6075 out of 6809 stocks based on 6 positive rankings and 9 negative rankings.

Positive Rankings
Estimated Revenue Growth
Heron Therapeutics Inc. rank is 123
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Heron Therapeutics Inc. is ranked 126.
SSValue
The StockSelector Value for Heron Therapeutics Inc. is $71.74. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Heron Therapeutics Inc. is ranked 346.
Debt-to-Equity
Heron Therapeutics Inc. rank is 558
Low Put/Call
Heron Therapeutics Inc. has a low Put/Call ratio of 0.34 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Heron Therapeutics Inc. is ranked 822.
10 Day Gain
Heron Therapeutics Inc. rank is 879
Negative Rankings
Negative Cash Growth
Heron Therapeutics Inc. rank is 218
Price-to-Sales
Heron Therapeutics Inc. rank is 370
Negative Net Margin
Heron Therapeutics Inc. rank is 392
90 Day Loss
Heron Therapeutics Inc. rank is 442
Negative ROA
Heron Therapeutics Inc. rank is 636
Negative ROE
Heron Therapeutics Inc. rank is 644
High vPut/Call
Heron Therapeutics Inc. has a high Put/Call ratio of 1.82 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Heron Therapeutics Inc. is ranked 777.
Price-to-Book
Heron Therapeutics Inc. rank is 1164
Down EPS Surprise
Heron Therapeutics Inc. missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.